412
Participants
Start Date
November 1, 2017
Primary Completion Date
December 31, 2022
Study Completion Date
December 31, 2022
CSII followed by Lina+MET
short-term intensive CSII followed by Linagliptin 5mg qd and Metformin 0.5g bid for 48 weeks
CSII followed by Lina
short-term intensive CSII followed by Linagliptin 5mg qd for 48 weeks
CSII followed by MET
short-term intensive CSII followed by Metformin 0.5g bid for 48 weeks
CSII alone
No OHA is given after short-term intensive CSII
endocrinology department of the first affiliated hospital of Sun Yat-sen University, Guangzhou
The Seventh Affiliated Hospital of Sun Yat-sen University
OTHER
Guangdong Provincial Hospital of Traditional Chinese Medicine
OTHER
Guangdong Provincial People's Hospital
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
Dongguan People's Hospital
OTHER_GOV
Clifford Hospital
UNKNOWN
Guangzhou Panyu Central Hospital
OTHER
Nanfang Hospital, Southern Medical University
OTHER
Chinese PLA General Hospital
OTHER
Peking University People's Hospital
OTHER
Shanghai 10th People's Hospital
OTHER
Shanghai Changzheng Hospital
OTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Huizhou Municipal Central Hospital
OTHER
Sun Yat-sen University
OTHER